O'KANE KIERAN (Chief Commercial Officer) sold 5.2% of their position (535.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $6.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2026ACC: 0000905148-26-000986
Officer· Chief Commercial Officer
Since Oct 2020
-535.00
Net shares
Net seller
$6.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.47K acquired · 2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.47K
Price / share
—
Trade value
—
% of position
16.5%
2/20/2026
8.88K→10.35K
Common Stock
Direct
Shares
−535.00
Price / share
$12.78
Trade value
$6.83K
% of position
5.2%
2/23/2026
10.35K→9.82K
Total
Net shares
+934.00
Net value
-$6.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | M · Option Exercise | +1.47K | — | — | 16.5% | 8.88K | 10.35K |
| Common Stock Direct | 2/23/2026 | S · Sale | −535.00 | $12.78 | $6.83K | 5.2% | 10.35K | 9.82K |
| Total | +934.00 | -$6.83K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.47K shares
Shares
−1.47K
Strike price
Held after
4.41K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.47K shares | 2/20/2026 | M · Option Exercise | −1.47K | — | 4.41K |